Filing Details
- Accession Number:
- 0000915913-21-000155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 17:47:11
- Reporting Period:
- 2021-08-10
- Accepted Time:
- 2021-08-10 17:47:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 915913 | Albemarle Corp | ALB | Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821) | 541692118 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1776484 | Goszcz Raphael Crawford | Albemarle Corporation 4250 Congress Street, Suite 900 Charlotte NC 28209 | President, Catalysts | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-10 | 5,021 | $118.75 | 22,340 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-10 | 3,220 | $240.48 | 19,120 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 1,801 | $241.16 | 17,319 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 4,500 | $240.05 | 12,819 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-08-10 | 5,021 | $0.00 | 5,021 | $118.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-02-23 | 2028-02-23 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.10 to 241.03, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.11 to 241.29, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.90 to $240.76, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- On February 23, 2018, the reporting person was granted a 10-year option exercisable for 5,021 shares of Common Stock. The option cliff-vested on 2/23/2021.
Billionaire Hedge Funds
